Merck Animal Health gets FDA nod for Bravecto Quantum

2 hours ago 1

• Healthcare

Uwe Krejci

• Merck Animal Health, part of Merck (NYSE:MRK), has received approval from the U.S. FDA for Bravecto Quantum, a new injectable treatment designed to protect dogs from fleas and ticks with just one dose per year.
• This product is anticipated to be available in veterinary clinics and hospitals by August, the company said.

More on Merck

• Merck Buys Verona Pharma: A Good Deal, But M&A Spree Must Continue
• Merck & Co.: A Pharma Titan At A Discount
• Dividend Yield Theory Says Merck Is A Buy
• FDA publishes more than 200 rejection letters in a bid to improve transparency
• Merck's doravirine/islatravir under FDA review for HIV

Recommended For You

1. Homepage
2. Politics
3. Merck Animal Health gets FDA nod for Bravecto Quantum